烟台论坛-烟台社区

标题: 这事靠谱吗都上热搜了 [打印本页]

作者: Schnheit 时间: 2023-1-29 09:45
提示: 作者被禁止或删除内容自动屏蔽

作者: 行云何处去 时间: 2023-1-29 09:48
生化危机的保护伞公司绝不是唯一的

作者: 虎山居士 时间: 2023-1-29 10:00
提示: 作者被禁止或删除内容自动屏蔽

作者: 发财哥 时间: 2023-1-29 10:03
智商检测题。。连这种货都知道的事情，国家都不知道，这两方中间肯定有一方是蠢货！

作者: 牛家卧 时间: 2023-1-29 10:04

行云何处去发表于 2023-1-29 09:48
生化危机的保护伞公司绝不是唯一的

我怀疑生化危机作者就是穿越回来的人员

作者: 小象已迷路 时间: 2023-1-29 10:05

作者: 牛马一生 时间: 2023-1-29 10:06
不解释

(, 下载次数: 11)

作者: 顺其自然也挺好 时间: 2023-1-29 10:08
很很多迫害妄想症患者

作者: 哈酒哈酒哈酒 时间: 2023-1-29 10:18

发财哥发表于 2023-1-29 10:03
智商检测题。。连这种货都知道的事情，国家都不知道，这两方中间肯定有一方是蠢货！

这个世界就大聪明多，大聪明们除了知道造国外的谣不犯法，至于是否符合常理那就不是大聪明要考虑的事情了

作者: 善待自己和他人 时间: 2023-1-29 10:55
路过打卡
笑而不语

作者: 桃木戒指 时间: 2023-1-29 15:27
换位思考，要我是公司高管，这么高利润，前提是可控的情况，别把我自己毒死了，我愿意冒这个风险

作者: lvjingyi123456 时间: 2023-1-29 15:33
Science
Products
2Pfizer
Pfizer Responds to Research Claims
Stories
Newsroom
About
Q
Contact Us
Friday, January 27, 2023 -08:00pm
New York, N.Y., January 27, 2023 - Allegations have recently been made related to gain of function and directed evolution
research at Pfizer and the company would like to set the record straight.
In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research. Working with collaborators, we have conducted research where the original SARS-CoV-2 virus has been used to express the spike protein from new variants of concern. This work is undertaken once a new variant of concern has been identified by public health authorities. This research provides a way for us to rapidly assess the ability of an existing vaccine to induce antibodies that neutralize a newly identified variant of concern. We then make this data available through peer reviewed scientific journals and use it as one of the steps to determine whether a
vaccine update is required.
In addition, to meet U.S. and global regulatory requirements for our oral treatment, PAXLOVID~", Pfizer undertakes in vitro work (e.g., in a laboratory culture dish) to identify potential resistance mutations to nirmatrelvir, one of PAXLOVID'S two components. With a naturally evolving virus, it is important to routinely assess the activity of an antiviral. Most of this work is conducted using computer simulations or mutations of the main protease-a non-infectious part of the virus.In a limited number of cases when a full virus does not contain any known gain of function mutations, such virus may be engineered to enable the assessment of antiviral activity in cells. In addition, in vitro resistance selection experiments are undertaken in cells incubated with SARS-CoV-2 and nirmatrelvir in our secure Biosafety level 3 (BSL3) laboratory to assess whether the main protease can mutate to yield resistant strains of the virus. It is important to note that these studies are required by U.S. and global regulators for all antiviral products and are carried out by many companies and academic institutions in the U.S. and around the world.
Fact-based information rooted in sound science is vitally important to overcoming the COVID-19 pandemic and Pfizer
remains committed to transparency and helping alleviate the devastating burden of this disease.

辉瑞官网的原文

作者: 发财哥 时间: 2023-1-29 16:13

桃木戒指发表于 2023-1-29 15:27
换位思考，要我是公司高管，这么高利润，前提是可控的情况，别把我自己毒死了，我愿意冒这个风险

请问你现在的职位是？

作者: 桃木戒指 时间: 2023-1-30 08:53

发财哥发表于 2023-1-29 16:13
请问你现在的职位是？

放心吧我是看大门的就是发表点个人的观点。

欢迎光临烟台论坛-烟台社区 (http://www.ytbbs.com/)